Clinical Trials in Ohio

Showing 3421-3440 of 10,042 trials

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

NCT05196828

Multi-center, prospective open-label extension study of noninvasive peripheral nerve stimulation (NPNS) with the NTX100 Neuromodulation System for patients with medication-refractory moderate- severe primary RLS

Restless Legs Syndrome

Noctrix Health, Inc.103 participantsStarted Dec 2021

San Leandro, California, United States • Colorado Springs, Colorado, United States • Atlanta, Georgia, United States +4 more locations

RECRUITING32 miles

The PREDICT Registry:

NCT03448926

This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions. Patients meeting the eligibility criteria (see below) will be eligible for participation and the investigators will obtain written informed consent. A central Institutional Review Board (IRB), WCG IRB, will approve the protocol and each participating institution.

DCIS

PreludeDx3,000 participantsStarted Feb 2018

Phoenix, Arizona, United States • Sacramento, California, United States • San Mateo, California, United States +12 more locations

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

The PREDICT Registry:

Find Trials by Condition in Ohio

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

A Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

Randomized Controlled Trial for Vestibular Treatment in Concussion

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

Breast Cancer Index (BCI) Registry

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients

A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients

International Weight Control Registry

Sildenafil Exercise: Role of PDE5 Inhibition

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST